BRCA1 and ovarian neoplasm: Interestingly, it has been demonstrated that there was increased BRCA1 protein expression, in the absence of BRCA1 reversion mutation, in two of four tumors carrying BRCT domain mutations in ovarian tumor samples resistant to carboplatin [72].